Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nerve Block | 11 | 2026 | 62 | 6.020 |
Why?
|
| Ultrasonography, Interventional | 14 | 2026 | 124 | 5.140 |
Why?
|
| Point-of-Care Systems | 8 | 2026 | 137 | 3.830 |
Why?
|
| Ultrasonography | 18 | 2026 | 491 | 3.530 |
Why?
|
| Emergency Service, Hospital | 20 | 2026 | 1165 | 3.440 |
Why?
|
| Emergency Medicine | 6 | 2026 | 195 | 3.070 |
Why?
|
| Intestinal Obstruction | 3 | 2026 | 54 | 2.390 |
Why?
|
| Pain Management | 6 | 2026 | 174 | 2.390 |
Why?
|
| Analgesia | 3 | 2026 | 37 | 1.670 |
Why?
|
| Cost Savings | 5 | 2026 | 60 | 1.530 |
Why?
|
| Clinical Competence | 4 | 2026 | 731 | 1.460 |
Why?
|
| Dexamethasone | 2 | 2025 | 214 | 1.460 |
Why?
|
| Pulmonary Edema | 3 | 2023 | 29 | 1.160 |
Why?
|
| Intestine, Small | 2 | 2026 | 84 | 1.110 |
Why?
|
| Lung | 7 | 2024 | 969 | 1.050 |
Why?
|
| Anesthesia, Conduction | 3 | 2021 | 11 | 1.040 |
Why?
|
| Sciatica | 1 | 2026 | 7 | 0.930 |
Why?
|
| Rural Health Services | 1 | 2026 | 34 | 0.930 |
Why?
|
| Reimbursement Mechanisms | 1 | 2026 | 41 | 0.930 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2026 | 43 | 0.920 |
Why?
|
| Artificial Intelligence | 3 | 2026 | 216 | 0.910 |
Why?
|
| Epinephrine | 1 | 2025 | 46 | 0.900 |
Why?
|
| Sciatic Nerve | 3 | 2026 | 31 | 0.900 |
Why?
|
| Abdominal Pain | 3 | 2020 | 99 | 0.870 |
Why?
|
| Crowdsourcing | 1 | 2024 | 15 | 0.830 |
Why?
|
| Family Practice | 1 | 2026 | 214 | 0.810 |
Why?
|
| Humans | 40 | 2026 | 65845 | 0.790 |
Why?
|
| Kidney Calculi | 1 | 2023 | 34 | 0.780 |
Why?
|
| Internship and Residency | 3 | 2026 | 800 | 0.780 |
Why?
|
| Radiation Exposure | 2 | 2024 | 25 | 0.760 |
Why?
|
| Infection Control | 2 | 2020 | 106 | 0.730 |
Why?
|
| Neoplasms | 2 | 2023 | 1378 | 0.720 |
Why?
|
| Emergencies | 2 | 2024 | 124 | 0.670 |
Why?
|
| Middle Aged | 12 | 2026 | 18501 | 0.650 |
Why?
|
| Brachial Plexus Block | 1 | 2020 | 2 | 0.640 |
Why?
|
| Shoulder Fractures | 1 | 2020 | 6 | 0.640 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 15 | 0.640 |
Why?
|
| Testicular Diseases | 1 | 2020 | 2 | 0.630 |
Why?
|
| Herpes Zoster | 1 | 2020 | 22 | 0.630 |
Why?
|
| Radiculopathy | 1 | 2020 | 21 | 0.630 |
Why?
|
| Back Pain | 1 | 2020 | 49 | 0.620 |
Why?
|
| Diverticulitis | 3 | 2025 | 38 | 0.610 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 274 | 0.610 |
Why?
|
| Thromboembolism | 1 | 2020 | 74 | 0.600 |
Why?
|
| Clinical Protocols | 1 | 2020 | 138 | 0.590 |
Why?
|
| Heart Failure | 2 | 2023 | 968 | 0.550 |
Why?
|
| Anesthetics, Local | 3 | 2025 | 73 | 0.540 |
Why?
|
| Monte Carlo Method | 4 | 2026 | 102 | 0.540 |
Why?
|
| Male | 15 | 2026 | 31410 | 0.520 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 206 | 0.500 |
Why?
|
| Registries | 3 | 2026 | 935 | 0.500 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 220 | 0.500 |
Why?
|
| Retrospective Studies | 6 | 2026 | 6957 | 0.500 |
Why?
|
| Female | 14 | 2026 | 34425 | 0.480 |
Why?
|
| Adult | 10 | 2026 | 17579 | 0.480 |
Why?
|
| Health Personnel | 1 | 2020 | 391 | 0.460 |
Why?
|
| Length of Stay | 3 | 2024 | 828 | 0.460 |
Why?
|
| United States | 6 | 2026 | 8189 | 0.430 |
Why?
|
| Prospective Studies | 5 | 2026 | 3340 | 0.420 |
Why?
|
| Aged | 8 | 2026 | 15147 | 0.420 |
Why?
|
| Patient Discharge | 1 | 2017 | 522 | 0.400 |
Why?
|
| Point-of-Care Testing | 3 | 2022 | 41 | 0.390 |
Why?
|
| Echocardiography | 3 | 2026 | 513 | 0.340 |
Why?
|
| Pain Measurement | 2 | 2024 | 344 | 0.340 |
Why?
|
| Ventricular Dysfunction, Right | 2 | 2021 | 50 | 0.320 |
Why?
|
| Time Factors | 1 | 2017 | 3779 | 0.310 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2026 | 1663 | 0.300 |
Why?
|
| Thorax | 3 | 2023 | 35 | 0.280 |
Why?
|
| Risk Evaluation and Mitigation | 1 | 2026 | 1 | 0.240 |
Why?
|
| Catheterization, Peripheral | 1 | 2026 | 51 | 0.230 |
Why?
|
| ROC Curve | 1 | 2026 | 295 | 0.230 |
Why?
|
| Video Recording | 1 | 2026 | 140 | 0.220 |
Why?
|
| Cost-Benefit Analysis | 1 | 2026 | 318 | 0.210 |
Why?
|
| Odds Ratio | 1 | 2026 | 757 | 0.210 |
Why?
|
| Aerospace Medicine | 1 | 2024 | 12 | 0.210 |
Why?
|
| Health Policy | 1 | 2026 | 191 | 0.200 |
Why?
|
| Space Flight | 1 | 2024 | 20 | 0.200 |
Why?
|
| Pain | 2 | 2024 | 400 | 0.200 |
Why?
|
| Feasibility Studies | 1 | 2026 | 593 | 0.200 |
Why?
|
| Transducers | 1 | 2022 | 24 | 0.180 |
Why?
|
| Machine Learning | 1 | 2024 | 197 | 0.180 |
Why?
|
| Medicaid | 1 | 2026 | 379 | 0.170 |
Why?
|
| Peripheral Nerves | 1 | 2021 | 34 | 0.170 |
Why?
|
| Medicare | 1 | 2026 | 629 | 0.170 |
Why?
|
| Anesthesiology | 1 | 2021 | 40 | 0.160 |
Why?
|
| Shoulder | 1 | 2020 | 29 | 0.160 |
Why?
|
| Morbidity | 1 | 2020 | 110 | 0.160 |
Why?
|
| Ventricular Function, Right | 1 | 2020 | 28 | 0.160 |
Why?
|
| Tricuspid Valve | 1 | 2020 | 28 | 0.160 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 26 | 0.150 |
Why?
|
| Patient Positioning | 1 | 2020 | 52 | 0.150 |
Why?
|
| Rural Population | 1 | 2022 | 225 | 0.150 |
Why?
|
| Program Evaluation | 1 | 2022 | 501 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 143 | 0.140 |
Why?
|
| Safety Management | 1 | 2020 | 139 | 0.140 |
Why?
|
| Influenza, Human | 1 | 2021 | 213 | 0.140 |
Why?
|
| Heart | 1 | 2021 | 298 | 0.140 |
Why?
|
| Hydronephrosis | 1 | 2018 | 10 | 0.140 |
Why?
|
| Cross Infection | 1 | 2020 | 170 | 0.140 |
Why?
|
| Kidney Pelvis | 1 | 2018 | 13 | 0.140 |
Why?
|
| Survival Rate | 1 | 2020 | 849 | 0.140 |
Why?
|
| Cohort Studies | 1 | 2024 | 2651 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 182 | 0.130 |
Why?
|
| Athletic Injuries | 1 | 2018 | 82 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2022 | 504 | 0.130 |
Why?
|
| Emergency Medical Services | 1 | 2020 | 264 | 0.120 |
Why?
|
| Program Development | 1 | 2017 | 208 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 2739 | 0.120 |
Why?
|
| Aged, 80 and over | 1 | 2026 | 5682 | 0.120 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 309 | 0.110 |
Why?
|
| Sensitivity and Specificity | 3 | 2025 | 1172 | 0.110 |
Why?
|
| Pandemics | 1 | 2020 | 691 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2017 | 1030 | 0.100 |
Why?
|
| Acute Disease | 2 | 2025 | 665 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2790 | 0.090 |
Why?
|
| Liability, Legal | 1 | 2026 | 17 | 0.060 |
Why?
|
| Malpractice | 1 | 2026 | 20 | 0.060 |
Why?
|
| Astronauts | 1 | 2024 | 7 | 0.050 |
Why?
|
| Radiation Dosage | 1 | 2024 | 140 | 0.050 |
Why?
|
| South Carolina | 1 | 2022 | 16 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2023 | 346 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 284 | 0.040 |
Why?
|
| Health Education | 1 | 2022 | 191 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2022 | 1117 | 0.040 |
Why?
|
| Young Adult | 2 | 2020 | 4883 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2026 | 2116 | 0.040 |
Why?
|
| Prognosis | 1 | 2023 | 1793 | 0.040 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2018 | 7 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 1719 | 0.030 |
Why?
|